This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: CROWN, LAURA, ADRIATIC, and PALOMA-3 Trials

679 views
June 14, 2024

Chapters

CROWN Trial & Lorlatinib FDA Approval

00:00

LAURA Study: Osimertinib in Stage III NSCLC

05:14

ADRIATIC: Durvalumab in Small Cell Lung Cancer

08:28

PALOMA Trial: Amivantamab Subcu vs IV

11:43

Survivability & Treatment Results Across Studies

14:47

Comments 1
Login to view comments. Click here to Login